On the other hand, in ACC patients, the rates for ATR and BRCA1 were not high (0 and 2.3%, respectively), while ATM and BRCA2 were 11.4 and 13.6%, respectively, which were both significantly higher compared with PDAC patients (p < 0.05 and p < 0.01, respectively). This evidence concerns the gene BRCA2 and adrenal cortex carcinoma.